The study of fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant central nervous system tumor.
Not Applicable
- Conditions
- malignant tumor of central nervous system
- Registration Number
- JPRN-UMIN000007872
- Lead Sponsor
- Department of Neurosurgery, Kobe University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet any of the conditions described bellow are excluded. 1) Patients with porphyria 2) Patients with hypersensitivity to 5-ALA or porphyrins 3) In case of renal insufficiency (serum creatinine is more than 2.0 mg/dL) 4) In case of hepatic insufficiency (total bilirubin >3 mg/dL, gamma-GTP >100 U/L, ptptprombin time <60%) 5) In case of known or suspected pregnancy,or woman who are breast-feeding.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method